Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
222
NCT00593151
Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 31, 2008
Completion: Mar 31, 2009
NCT00863239
Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV
Phase: Phase 2
Start: Mar 31, 2009
Completion: Nov 30, 2011
NCT00953589
480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV)
Start: Jul 31, 2009
Completion: Jan 31, 2011